Janni W - Search Results

1

Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.

Müller V, Hein A, Hartkopf AD, Fasching PA, Kolberg HC, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wallwiener M, Beckmann MW, Schneeweiss A, Belleville E, Uhrig S, Wimberger P, Hielscher C, Meyer J, Wurmthaler LA, Kurbacher CM, Wuerstlein R, Untch M, Janni W, Taran FA, Lux MP, Wallwiener D, Brucker SY, Fehm TN, Michel LL. Müller V, et al. Among authors: janni w. Eur J Cancer. 2022 Sep;172:13-21. doi: 10.1016/j.ejca.2022.05.015. Epub 2022 Jun 18. Eur J Cancer. 2022. PMID: 35728342 Free article.

2

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmüller G, Schlimok G. Braun S, et al. Among authors: janni w. N Engl J Med. 2000 Feb 24;342(8):525-33. doi: 10.1056/NEJM200002243420801. N Engl J Med. 2000. PMID: 10684910 Free article.

3

Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.

Janni W, Gastroph S, Hepp F, Kentenich C, Rjosk D, Schindlbeck C, Dimpfl T, Sommer H, Braun S. Janni W, et al. Cancer. 2000 May 15;88(10):2252-9. doi: 10.1002/(sici)1097-0142(20000515)88:10<2252::aid-cncr8>3.0.co;2-q. Cancer. 2000. PMID: 10820346

4

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence.

Janni W, Hepp F, Rjosk D, Kentenich C, Strobl B, Schindlbeck C, Hantschmann P, Sommer H, Pantel K, Braun S. Janni W, et al. Cancer. 2001 Jul 1;92(1):46-53. doi: 10.1002/1097-0142(20010701)92:1<46::aid-cncr1290>3.0.co;2-6. Cancer. 2001. PMID: 11443608

5

Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?

Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, Rammel G, Sommer H, Dimpfl T, Friese K. Rack B, et al. Among authors: janni w. Breast Cancer Res Treat. 2003 Nov;82(2):83-92. doi: 10.1023/B:BREA.0000003955.73738.9e. Breast Cancer Res Treat. 2003. PMID: 14692652

6

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.

Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K. Janni W, et al. Cancer. 2005 Mar 1;103(5):884-91. doi: 10.1002/cncr.20834. Cancer. 2005. PMID: 15666325 Free article.

7

A pooled analysis of bone marrow micrometastasis in breast cancer.

Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K. Braun S, et al. Among authors: janni w. N Engl J Med. 2005 Aug 25;353(8):793-802. doi: 10.1056/NEJMoa050434. N Engl J Med. 2005. PMID: 16120859 Free article.

8

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.

Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, Schindlbeck C, Wallwiener D, Borgen E, Naume B, Pantel K, Solomayer E. Fehm T, et al. Among authors: janni w. Cancer. 2006 Sep 1;107(5):885-92. doi: 10.1002/cncr.22076. Cancer. 2006. PMID: 16874814 Free article.

9

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Riethdorf S, et al. Among authors: janni w. Clin Cancer Res. 2007 Feb 1;13(3):920-8. doi: 10.1158/1078-0432.CCR-06-1695. Clin Cancer Res. 2007. PMID: 17289886

10

Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.

Rack B, Schindlbeck C, Jückstock J, Genss EM, Hepp P, Lorenz R, Tesch H, Schneeweiss A, Beckmann MW, Lichtenegger W, Sommer H, Friese K, Janni W; SUCCESS Study Group. Rack B, et al. Among authors: janni w. Anticancer Res. 2010 May;30(5):1837-41. Anticancer Res. 2010. PMID: 20592389 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

542 results

Search Page